ACM
RAPT

Aquatic Capital Management’s RAPT Therapeutics RAPT Stock Holding History

Aquatic Capital Management’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-63
Closed -$12K – 1743
2022
Q3 		$12K Buy
+63
New +$11.9K ﹤0.01% 1045
2022
Q2 		– Sell
-38
Closed -$7K – 1508
2022
Q1 		$7K Sell
38
-150
-80% -$28.3K 0.01% 762
2021
Q4 		$55K Buy
+188
New +$50.3K 0.11% 287

Other funds holding RAPT

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Aquatic Capital Management's RAPT Position: Q4 2022 in Review

Aquatic Capital Management sold out of RAPT Therapeutics (RAPT) in Q4 2022, closing a stake of 63 shares — an estimated $12K sold.

Aquatic Capital Management first reported a position in RAPT in Q4 2021 and held it in 3 quarters. The position peaked at $55K in Q4 2021. 95 funds tracked by Wall St. Rank hold RAPT as of Q4 2022.

  • Aquatic Capital Management reported no remaining RAPT Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Aquatic Capital Management sold 63 RAPT Therapeutics shares in Q4 2022, an estimated $12K.
  • Aquatic Capital Management first reported a position in RAPT Therapeutics in Q4 2021 and held it in 3 quarters.
  • Aquatic Capital Management's RAPT Therapeutics position peaked at $55K in Q4 2021.
  • 95 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q4 2022.

Based on Aquatic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.